JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Z.
Right arrow Articles by Nattel, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Z.
Right arrow Articles by Nattel, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*4-AMINOPYRIDINE
*POTASSIUM
*QUINIDINE
*QUINIDINE SULFATE

Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes

Z Wang, B Fermini and S Nattel

Department of Medicine, Montreal Heart Institute, Quebec, Canada.

Antiarrhythmic drugs prevent atrial reentrant arrhythmias by prolonging atrial action potential duration and refractoriness. The ionic mechanisms by which antiarrhythmic drugs alter human atrial repolarization are poorly understood. The present study was designed to assess the concentration-, voltage-, time- and frequency-dependent effects of the antiarrhythmic agents quinidine and flecainide, as well as of the K+ channel blocker 4-aminopyridine, on the calcium- independent transient outward current (Ito1) and the ultrarapid delayed rectifier current (IKur) in isolated human atrial myocytes. Quinidine and flecainide blocked Ito1 at clinically relevant concentrations. Block of Ito1 by quinidine was use and frequency dependent, whereas block by flecainide was frequency independent, and 4-aminopyridine showed use-dependent unblocking. Depolarizing prepulses enhanced flecainide block and reduced 4-aminopyridine block in a fashion suggesting a preferential interaction with the inactivated state for flecainide and with the resting, closed state for 4-aminopyridine. Quinidine block depended on the potential of a depolarizing test pulse in a fashion suggesting open channel block. All three drugs accelerated channel inactivation during depolarization at 1 Hz and failed to block Ito1 during initial current rise, with block appearing with time constants of 6.3 +/- 1.2 msec for flecainide, 14.5 +/- 4.2 msec for quinidine and 3.0 +/- 0.9 msec for 4-aminopyridine at 16 degrees C, suggesting a role for channel opening in block development. Quinidine blocked IKur at clinical concentrations, whereas flecainide had no effect on IKur. Quinidine block of IKur was voltage dependent, with part of the voltage dependence attributable to open-channel block and the remainder compatible with a blocking site within the voltage field at a position subject to 23% of the total electrical field. Quinidine's blocking actions on IKur were similar to those previously reported for block of a cardiac K+ channel clone of the Shaker family (Kv1.5), for which IKur is believed to be the equivalent native current. These results indicate that flecainide and quinidine block Ito1, and quinidine blocks IKur, in human atrial myocytes in a state-dependent fashion. Because drug effects are manifest at clinically relevant concentrations, and Ito1 and IKur have been shown to be potentially important currents in human atrial repolarization, these findings are relevant to understanding the ionic mechanisms underlying the clinical antiarrhythmic properties of these drugs.

Volume 272, Issue 1, pp. 184-196, 01/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. E. Kim, H. S. Ahn, B. H. Choi, H.-J. Jang, M.-J. Kim, D.-J. Rhie, S.-H. Yoon, Y.-H. Jo, M.-S. Kim, K.-W. Sung, et al.
Open Channel Block of A-Type, Kv4.3, and Delayed Rectifier K+ Channels, Kv1.3 and Kv3.1, by Sibutramine
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 753 - 762.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. Liu, D. R. Hansen, I. Kim, and T. A. Gilbertson
Expression and characterization of delayed rectifying K+ channels in anterior rat taste buds
Am J Physiol Cell Physiol, October 1, 2005; 289(4): C868 - C880.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Herrera, A. Mamarbachi, M. Simoes, L. Parent, R. Sauve, Z. Wang, and S. Nattel
A Single Residue in the S6 Transmembrane Domain Governs the Differential Flecainide Sensitivity of Voltage-Gated Potassium Channels
Mol. Pharmacol., August 1, 2005; 68(2): 305 - 316.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Tamargo, R. Caballero, R. Gomez, C. Valenzuela, and E. Delpon
Pharmacology of cardiac potassium channels
Cardiovasc Res, April 1, 2004; 62(1): 9 - 33.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
H. Liu, J. Atkins, and R. S. Kass
Common Molecular Determinants of Flecainide and Lidocaine Block of Heart Na+ Channels: Evidence from Experiments with Neutral and Quaternary Flecainide Analogues
J. Gen. Physiol., February 24, 2003; 121(3): 199 - 214.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Godreau, R. Vranckx, and S. N. Hatem
Mechanisms of Action of Antiarrhythmic Agent Bertosamil on hKv1.5 Channels and Outward Potassium Current in Human Atrial Myocytes
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 612 - 620.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
A.E. Lacerda, J. Kramer, K.-Z. Shen, D. Thomas, and A.M. Brown
Comparison of block among cloned cardiac potassium channels by non-antiarrhythmic drugs
Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K23 - K30.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
D. J. Huelsing, A. E. Pollard, and K. W. Spitzer
Transient outward current modulates discontinuous conduction in rabbit ventricular cell pairs
Cardiovasc Res, March 1, 2001; 49(4): 779 - 789.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Wang, H. Shi, L. Zhang, M. Pourrier, B. Yang, S. Nattel, and Z. Wang
Nicotine Is a Potent Blocker of the Cardiac A-Type K+ Channels : Effects on Cloned Kv4.3 Channels and Native Transient Outward Current
Circulation, September 5, 2000; 102(10): 1165 - 1171.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Han, Z. Wang, and S. Nattel
A comparison of transient outward currents in canine cardiac Purkinje cells and ventricular myocytes
Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H466 - H474.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Lei, H. Honjo, I. Kodama, and M.R. Boyett
Characterisation of the transient outward K+ current in rabbit sinoatrial node cells
Cardiovasc Res, June 1, 2000; 46(3): 433 - 441.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Yue, J. L. Feng, Z. Wang, and S. Nattel
Effects of ambasilide, quinidine, flecainide and verapamil on ultra-rapid delayed rectifier potassium currents in canine atrial myocytes
Cardiovasc Res, April 1, 2000; 46(1): 151 - 161.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Nattel, C. Matthews, E. De Blasio, W. Han, D. Li, and L. Yue
Dose-Dependence of 4-Aminopyridine Plasma Concentrations and Electrophysiological Effects in Dogs : Potential Relevance to Ionic Mechanisms In Vivo
Circulation, March 14, 2000; 101(10): 1179 - 1184.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. Wang, S. Swirp, and H. Duff
Age-dependent response of the electrocardiogram to K+ channel blockers in mice
Am J Physiol Cell Physiol, January 1, 2000; 278(1): C73 - C80.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Nagatomo, C. T. January, and J. C. Makielski
Preferential Block of Late Sodium Current in the LQT3 Delta KPQ Mutant by the Class IC Antiarrhythmic Flecainide
Mol. Pharmacol., January 1, 2000; 57(1): 101 - 107.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Shi, H.-Z. Wang, and Z. Wang
Extracellular Ba2+ blocks the cardiac transient outward K+ current
Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H295 - H299.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. O. Verkerk, M. W. Veldkamp, F. Abbate, G. Antoons, L. N. Bouman, J. H. Ravesloot, and A. C. G. van Ginneken
Two types of action potential configuration in single cardiac Purkinje cells of sheep
Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1299 - H1310.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G.-N. Tseng
Different State Dependencies of 4-Aminopyridine Binding to rKv1.4 and rKv4.2: Role of the Cytoplasmic Halves of the Fifth and Sixth Transmembrane Segments
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 569 - 577.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
E. Carmeliet
Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias
Physiol Rev, July 1, 1999; 79(3): 917 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. J Snyders
Structure and function of cardiac potassium channels
Cardiovasc Res, May 1, 1999; 42(2): 377 - 390.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Tachibana, M. Yamaki, I. Kubota, T. Watanabe, S. Yamauchi, and H. Tomoike
Intracoronary Flecainide Induces ST Alternans and Reentrant Arrhythmia on Intact Canine Heart : A Role of 4-Aminopyridine–Sensitive Current
Circulation, March 30, 1999; 99(12): 1637 - 1643.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Sobko, A. Peretz, O. Shirihai, S. Etkin, V. Cherepanova, D. Dagan, and B. Attali
Heteromultimeric Delayed-Rectifier K+ Channels in Schwann Cells: Developmental Expression and Role in Cell Proliferation
J. Neurosci., December 15, 1998; 18(24): 10398 - 10408.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. I. Nenov, W. J. Crumb Jr, J. D. Pigott, L. H. Harrison Jr, and C. W. Clarkson
Quinidine Interactions With Human Atrial Potassium Channels : Developmental Aspects
Circ. Res., December 14, 1998; 83(12): 1224 - 1231.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. S. Lee and E. W. Lee
Ionic Mechanism of Ibutilide in Human Atrium: Evidence for a Drug-Induced Na+ Current Through a Nifedipine Inhibited Inward Channel
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 9 - 22.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
A. Nygren, C. Fiset, L. Firek, J. W. Clark, D. S. Lindblad, R. B. Clark, and W. R. Giles
Mathematical Model of an Adult Human Atrial Cell : The Role of K+ Currents in Repolarization
Circ. Res., January 23, 1998; 82(1): 63 - 81.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. A. Grace and A. J. Camm
Quinidine
N. Engl. J. Med., January 1, 1998; 338(1): 35 - 45.
[Full Text] [PDF]


Home page
CirculationHome page
E. A. Sosunov, E. P. Anyukhovsky, and M. R. Rosen
Effects of Quinidine on Repolarization in Canine Epicardium, Midmyocardium, and Endocardium : I. In Vitro Study
Circulation, December 2, 1997; 96(11): 4011 - 4018.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
E. Delpon, C. Valenzuela, P. Gay, L. Franqueza, D. J Snyders, and J. Tamargo
Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels
Cardiovasc Res, August 1, 1997; 35(2): 341 - 350.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Feng, B. Wible, G.-R. Li, Z. Wang, and S. Nattel
Antisense Oligodeoxynucleotides Directed Against Kv1.5 mRNA Specifically Inhibit Ultrarapid Delayed Rectifier K+ Current in Cultured Adult Human Atrial Myocytes
Circ. Res., April 19, 1997; 80(4): 572 - 579.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Feng, Z. Wang, G.-R. Li, and S. Nattel
Effects of Class III Antiarrhythmic Drugs on Transient Outward and Ultra-rapid Delayed Rectifier Currents in Human Atrial Myocytes
J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 384 - 392.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
R. Coronel, T. Opthof, P. Taggart, J. Tytgat, and M. Veldkamp
Differential electrophysiology of repolarisation from clone to clinic
Cardiovasc Res, March 1, 1997; 33(3): 503 - 517.
[PDF]


Home page
Cardiovasc ResHome page
S. W. Yeola and D. J. Snyders
Electrophysiological and pharmacological correspondence between Kv4.2 current and rat cardiac transient outward current
Cardiovasc Res, March 1, 1997; 33(3): 540 - 547.
[Abstract] [PDF]


Home page
CirculationHome page
D. M. Roden, R. Lazzara, M. Rosen, P. J. Schwartz, J. Towbin, and G. M. Vincent
Multiple Mechanisms in the Long-QT Syndrome: Current Knowledge, Gaps, and Future Directions
Circulation, October 15, 1996; 94(8): 1996 - 2012.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
J. E. Dixon, W. Shi, H.-S. Wang, C. McDonald, H. Yu, R. S. Wymore, I. S. Cohen, and D. McKinnon
Role of the Kv4.3 K+ Channel in Ventricular Muscle: A Molecular Correlate for the Transient Outward Current
Circ. Res., October 1, 1996; 79(4): 659 - 668.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
S. W. Yeola, T. C. Rich, V. N. Uebele, M. M. Tamkun, and D. J. Snyders
Molecular Analysis of a Binding Site for Quinidine in a Human Cardiac Delayed Rectifier K+ Channel : Role of S6 in Antiarrhythmic Drug Binding
Circ. Res., June 1, 1996; 78(6): 1105 - 1114.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
K. Hu, D. Duan, G.-R. Li, and S. Nattel
Protein Kinase C Activates ATP-Sensitive K+ Current in Human and Rabbit Ventricular Myocytes
Circ. Res., March 1, 1996; 78(3): 492 - 498.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics.